Acessibilidade
A+
A-
Institucional

SASB

Home > SASB > Patient health outcomes > HC-DR-260b.2
Data pertaining to 2023
Overview Energy management in retail Management of controlled substances Drug supply chain integrity Activity metrics Patient health outcomes Data security and privacy

Patient health outcomes

Seta para baixo
GRI HC-DR-260b.2
Description of policies and practices to prevent prescription dispensing errors

We have a Manual of Good Pharmaceutical Practices through which pharmacists are instructed to evaluate the following aspects in the prescription: readability and absence of erasures and amendments, user identification, drug identification, concentration, posology, dosage form and quantity, dosage, treatment duration, place and date of issue, signature and identification of the prescriber bearing the registration number with the respective professional council. In addition, when dispensing, pharmacists must check the drug identification, expiration date and the packaging integrity. If there is a need to clarify any problem or doubt detected when evaluating the prescription, the prescriber is contacted, in accordance with Anvisa Resolution RDC no. 44/2009. The dispensing of generic and/or similar drugs, with regard to interchangeability, is carried out in accordance with the provisions of specific legislation. In accordance with RDC no. 52, dated November 14, 2013, and Act no. 12.871/2013, Section 16 (§3), the Ministry of Health’s Special Registration (RMS) can be accepted in place of the Regional Council of Medicine (CRM) registration number in prescription notifications, prescription drugs, antimicrobial prescriptions or in any other situation in which such registration number is required by health regulations.

© 2024 RaiaDrogasil – Todos os direitos reservados.  |  Produzido por Plank
Português Português English English